Twitxy Saved

Ashvin Bachireddy

@ashvinb

Managing Partner at @svangel
San Francisco, CA Joined February 2009
1.2K Following 4.4K Followers 1.4K Posts

Latest posts 5

Ashvin Bachireddy @ashvinb
Faster inference means more reasoning in the same amount of time. That could bring some of the hardest problems in science and medicine within reach. Proud to be investors in @fractile_ai! Huge congrats to @goodwin_ml and the team!
Walter Goodwin Verified account @goodwin_ml 4h
We have raised a $720M Series C, led by @ThriveCapital, @lightspeedvp, @Redpoint and @foundersfund, to allow us to run faster in shipping the world's fastest chips for AI.

We've seen over the past year that many of the hardest problems that humanity faces - in science, medicine, physics - may be solved in our lifetimes by AI.

One hallmark of AI applied to the toughest problems is that extreme scaling of inference compute becomes vital. In tackling a Millenium Prize problem, for instance, @OpenAI ran 10,000 parallel agents for 80 hours. Costing over $10M, this level of capability is far from democratised today.

When we study agentic scaling, there are two paths: parallel, and sequential. In just the same way that most hard problems solved by humans don't parallelise efficiently, we see the same with agents: fewer agents, thinking for longer, scales better in every way except for the time that you wait for a response.

Building radically faster inference hardware, which doesn't force a trade-off on throughput, model sizes or context lengths, is a key step in bringing down the cost and time we incur in solving our hardest problems.

We're thrilled to be backed to bring this to the world!
View quoted post on X
Ashvin Bachireddy @ashvinb
Microsoft reports >50% higher throughput for Copilot workloads quarter over quarter. The effective supply of compute can grow faster than the installed base of hardware. Efficiency gains deserve attention alongside the capex numbers.
Ashvin Bachireddy @ashvinb
As AI expands the supply of promising drug candidates, clinical development becomes an even tighter bottleneck. Faster discovery needs capacity downstream to reach patients. Excited to see @BenjamineYLiu, @lintaho and @FormationBio put $600M toward expanding that capacity!
Ben Liu Verified account @BenjamineYLiu Oct 28
Today we’re announcing the $600M Formation Bio Drug Development Accelerator Fund.

@lintaho and I started @FormationBio because we believed the biggest bottleneck in bringing new medicines to patients wasn’t drug discovery, but drug development.

As AI dramatically accelerates discovery, that bottleneck is only becoming more acute. Without the capital and capacity to advance promising drugs through clinical trials, much of that progress won’t translate into medicines for patients.

Our new Fund brings together dedicated capital, drug development expertise, and AI-powered development capabilities to acquire promising drugs and advance them through the clinic.
View quoted post on X
Ashvin Bachireddy @ashvinb
A few minutes back on every patient visit will add up quickly. Giving clinicians better context for those visits could matter even more. Lots to be excited about in what @ShivdevRao and the @AbridgeHQ team are building.
Shiv Rao, MD Verified account @ShivdevRao Oct 30
The @AbridgeHQ Assistant is the AI assistant for healthcare.

Our vision is that every clinician has a team of agents figuring out all the things they want to know, helping them ask the right questions, leverage the right evidence, and improve patient care and outcomes.

Now in use at 300+ health systems.
View quoted post on X